G G Steinmann1, F Rosenkaimer, G Leitz. Show Affiliations » 1. Boehringer Ingelheim, Biberach, Germany.
Abstract
Entities: Gene
Mesh： See more » Clinical Trials as TopicFever/chemically inducedGastrointestinal Diseases/chemically inducedGranulomatous Disease, Chronic/therapyHematologic Diseases/chemically inducedHumansImmunologic Factors/adverse effectsImmunologic Factors/therapeutic useInterferon Type I/adverse effectsInterferon Type I/therapeutic useInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useInterferon-gamma/adverse effectsInterferon-gamma/therapeutic useNeoplasms/therapyNervous System Diseases/chemically inducedPain/chemically inducedRecombinant ProteinsRemission InductionSkin Diseases/chemically induced
Substances： See more » Immunologic FactorsInterferon Type IInterferon-alphaRecombinant ProteinsInterferon-gamma
Year: 1993 PMID： 8458713
Source DB: PubMed Journal: Int Rev Exp Pathol ISSN： 0074-7718